Incidence of liver‐related morbidity and mortality in a population cohort of non‐alcoholic fatty liver disease

Administrative coding in electronic health care record‐based research of NAFLD: an expert panel consensus statement

(2021) Hannes Hagström et al.   HEPATOLOGY

NAFLD as a driver of chronic kidney disease

(2020) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study

(2020) Verena Katzke et al.   BMJ Open

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

(2020) Cristiana Bianco et al.   JOURNAL OF HEPATOLOGY

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts

(2019) Myriam Alexander et al.   BMC Medicine

PS-059-Increased healthcare resource utilization and costs in nonalcoholic fatty liver disease/non-alcoholic steatohepatitis patients with liver disease progression: A multivariate analysis of french national hospital care

(2019) Jerome Boursier et al.   JOURNAL OF HEPATOLOGY

PS-060-Increasing risk of disease progression and mortality in nonalcoholic fatty liver disease/non-alcoholic steatohepatitis patients with advanced liver disease: A german real-world analysis

(2019) Ali Canbay et al.   JOURNAL OF HEPATOLOGY

Risks of light and moderate alcohol use in fatty liver disease – follow‐up of population cohorts

(2019) Fredrik Åberg et al.   HEPATOLOGY

The Risk of Incident Extrahepatic Cancers is higher in Nonalcoholic Fatty Liver Disease than Obesity - a Longitudinal Cohort Study

(2019) Alina M. Allen et al.   JOURNAL OF HEPATOLOGY

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease

(2019) Fasiha Kanwal et al.   HEPATOLOGY

PNPLA3 I148M and liver fat and fibrosis scores predict liver disease mortality in the United States population

(2019) Aynur Unalp‐Arida et al.   HEPATOLOGY

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease

(2019) Hongjie Ou et al.   Canadian Journal of Gastroenterology and Hepatology

Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies

(2019) Fredrik Åberg et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Association of Liver Fibrosis With Cardiovascular Diseases in the General PopulationCLINICAL PERSPECTIVE

(2018) Mohammad R. Ostovaneh et al.   Circulation-Cardiovascular Imaging

Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population

(2018) Fredrik Åberg et al.   HEPATOLOGY

NAFLD and cancer: More cause for concern?

(2018) Peter Jepsen et al.   JOURNAL OF HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Cohort Profile: The National FINRISK Study

(2017) Katja Borodulin et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The association of unemployment with glucose metabolism: a systematic review and meta-analysis

(2017) Tuulia Varanka-Ruuska et al.   International Journal of Public Health

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

(2017) P. Dongiovanni et al.   JOURNAL OF INTERNAL MEDICINE

Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women

(2017) Silvia Stringhini et al.   LANCET

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

(2017) Anna M. Diehl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States

(2017) Michael H. Le et al.   PLoS One

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

(2016) Nathan R. Hill et al.   PLoS One

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Marital status, labour force activity and mortality: A study in the USA and six European countries

(2015) Karen Van Hedel et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

(2014) L. Fedchuk et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts

(2014) D. J. McLernon et al.   BMJ Open

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

(2014) Hannele Yki-Järvinen   Lancet Diabetes & Endocrinology

Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2013) Paul Angulo et al.   GASTROENTEROLOGY

Quality of the Finnish Hospital Discharge Register: A systematic review

(2012) Reijo Sund   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

(2011) Zobair M. Younossi et al.   HEPATOLOGY

Effects of the Wars on Smoking Among Veterans

(2010) Lori A. Bastian et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION